跳至主導覽 跳至搜尋 跳過主要內容

Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)

  • Yoko Kano*
  • , Mikiko Tohyama
  • , Michiko Aihara
  • , Setsuko Matsukura
  • , Hideaki Watanabe
  • , Hirohiko Sueki
  • , Masafumi Iijima
  • , Eishin Morita
  • , Hiroyuki Niihara
  • , Hideo Asada
  • , Kenji Kabashima
  • , Hiroaki Azukizawa
  • , Hideo Hashizume
  • , Keisuke Nagao
  • , Hayato Takahashi
  • , Riichiro Abe
  • , Chie Sotozono
  • , Michiko Kurosawa
  • , Yumi Aoyama
  • , Chia Yu Chu
  • Wen Hung Chung, Tetsuo Shiohara
*此作品的通信作者
  • Kyorin University
  • Ehime University
  • Yokohama City University
  • Showa Medical University
  • Shimane University
  • Nara Medical University
  • Kyoto University
  • The University of Osaka
  • Shimada Municipal Hospital
  • Keio University
  • Hokkaido University
  • Kyoto Prefectural University of Medicine
  • Juntendo University
  • Okayama University
  • National Taiwan University
  • Chang Gung Memorial Hospital

研究成果: 期刊稿件 › 文章 › 同儕審查

124 引文 斯高帕斯(Scopus)

摘要

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) is a severe adverse drug reaction caused by specific drug. It is characterized by visceral organ involvement and reactivation of various human herpesviruses. Although sporadic reports have documented certain conditions that appear after the resolution of DIHS/DRESS, little information is available on sequelae after resolution of DIHS/DRESS in a large patient population. The Asian Research Committee on Severe Cutaneous Adverse Reactions, comprised of doctors from Japan and Taiwan, conducted a survey on sequelae and deterioration of the underlying disease in patients with DIHS/DRESS. This was achieved by directly interviewing patients who had been followed-up by experts or through a questionnaire mailed to patients. Questions were asked about new onset cardiovascular disease, collagen disease or autoimmune disease, gastrointestinal disease, renal disease, respiratory disease, neoplasms, and other diseases such as herpes zoster and diabetes mellitus, as well as deterioration of the underlying disease. A total of 145 patients were analyzed in this study. The following newly developed diseases after recovery from DIHS/DRESS were observed: Graves' disease (n = 2), Hashimoto's disease (n = 3), painless thyroiditis (n = 2), fulminant type 1 diabetes mellitus (n = 5), and infectious diseases (n = 7). Several DIHS/DRESS patients with pre-existing renal dysfunction required lifelong hemodialysis. DIHS/DRESS is a condition that increases the risk of new onset of disease. Long-term observation of DIHS/DRESS can provide an opportunity to investigate substantial diseases from onset to the full-blown stage. Patients with DIHS/DRESS require careful long-term follow-up.

原文英語
頁(從 - 到)276-282
頁數7
期刊Journal of Dermatology
卷42
發行號3
DOIs
出版品狀態已出版 - 01 03 2015
對外發佈是

文獻附註

Publisher Copyright:
© 2015 Japanese Dermatological Association.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)」主題。共同形成了獨特的指紋。

引用此